Sativa Investments PLC Cannabinoid research with globally-recognised King’s College London

Sativa Investments PLC (NEX: SATI), the UK’s first medicinal cannabis investment vehicle, has entered into a research agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory diseases.

Geremy Thomas, founder and Chief Executive Officer of Sativa Investments, said: “With the UK catching up fast in terms of recognising the benefits of medicinal cannabis, in-country research from the globally-recognised King’s College London will assist the medical profession, Government and Regulators in their deliberations.

“As the UK’s first medicinal cannabis investment vehicle, Sativa remains at the forefront of this fast-developing sector, which effectively mirrors what has been happening in North America since medicinal cannabis was first legalised in Canada in 2001, more than 17 years ago,”

The research will be led by Professor Clive Page OBE PhD Professor of Pharmacology at King’s College London. Professor Page is a world authority on the pharmacology of inflammation and respiratory disease, having published over 250 scientific papers. He is a Fellow of the Royal Society of Biology and the British Pharmacological Society, and was awarded an OBE in 2017 for his “Services to Pharmacology.”

Sativa, which has a medicinal cannabis grower’s licence in process through the Home Office Drugs Licensing and Compliance Unit, will, subject to regulatory consent, supply the university, to order, with specific strains of cannabis plants that contain various combinations of the spectrum of at least 113 known cannabinoids. The Company is able to provide this service through a combination of its commercial agreement with investee business Canada-based Veritas Pharma Inc., which specialises in identifying the optimum cultivation of various strains, and Sativa’s own on-site and highly successful testing facility, PhytoVista Laboratories, that has already undertaken over 1,000 forensic tests relating to a wide variety of cannabinoids, and is accredited and recommended by the UK’s Cannabis Trades Association (“CTA”).

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Sativa Investments plc

    More articles like this

    DirectorsTalk

    CBD as a novel food: the UK’s stance post-Brexit

    The UK FSA’s announcements that it will consider novel food applications for CBD products stands in contrast to the position taken by the European Commission during the summer of 2020, who have currently ‘paused’ novel food

    DirectorsTalk

    What cannabinoids are found in CBD oils?

    CBD oils can be purely made from seeds or they can be a combination of cannabinoids, flavonoids, and terpenes. Every CBD oil is a little bit different, and you will want to make sure you read

    DirectorsTalk

    How the UK CBD industry is thriving in uncertain times

    This year covid-19 has hit hard with far-reaching economic implications for countries around the world. The United Kingdom is no exception as the economy has taken the brunt of the pandemic’s negative effects. However certain markets

    DirectorsTalk

    UK CBD market on a high

    Just when you thought the ‘hype’ around CBD adoption was a passing fad, UK’s nascent CBD market happens to be among the few industries maintaining an upward growth amidst the recent COVID-19 pandemic devastation in the

    DirectorsTalk

    How to integrate CBD oil into your diet

    The internet is awash with information and testimonies on the benefits of CBD oil and the potential that it has in alleviating a number of ailments. Whether or not some of these claims are true is

    DirectorsTalk

    Why should you choose CBD oil?

    Cannabidiol (CBD) is a non-psychoactive yet active chemical component among cannabinoids, a group of compounds found in marijuana plants otherwise known as Cannabis sativa. Conversely, Tetrahydrocannabinol (THC) is the principal psychoactive component that causes an intoxicating

    DirectorsTalk

    A guide to CBD

    What is CBD? CBD – It’s a relatively new product, but how can it benefit you? Most people haven’t even heard of it and yet it’s starting to appear in conversations around sports, food and beauty

    Sativa Group

    Is CBD oil legal in the UK?

    The legal status of CBD in the UK is reflected in many countries worldwide, with the main difference being the levels of THC allowed in the finished product. CBD has seen such a rapid rise to

    Sativa Group

    Sativa Group joins the ACI toxicology study

    As part of the Sativa Group PLC (AQUIS:SATI) ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the

    Sativa Group

    A comprehensive guide to CBD in the UK

    CBD is being added to products across the retail spectrum from food to make-up. According to claims by the Centre for Medical Cannabis, six million people in the UK have tried CBD, and this year the

    Sativa Group

    A new cannabis wellness era: A history of CBD

    Cannabis Sativa L. has been utilised for a large variety of ailments, industrial applications, and ceremonial uses for millennia. Evidence gathered from significant ancient sites has revealed that the plant was important, and even sacred, in

    Sativa Group

    How CBD can help level up your workout

    With gyms closed and group classes relegated to the online world, at-home workouts are the new normal. Feeling a bit lackluster after months of squats in your living room? Want a new solution so you can

    Sativa Group

    What is CBD? How does it work?

    What is CBD? It’s in everything from beauty products to lattes, but those three letters are thrown around so much that you’d be forgiven for not knowing what CBD is, exactly. More importantly, you might be wondering, is CBD safe?

    Sativa Group

    Sativa Group CSE conditionally approves Sativa Wellness Group

    Sativa Group plc (AQUIS:SATI) has announced that the Canadian Securities Exchange conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously